Will taking Wellbutrin (bupropion) 75mg twice a day (bid) affect sleep?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 19, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Will Wellbutrin 75mg BID Affect Sleep?

Yes, Wellbutrin (bupropion) 75mg twice daily can significantly affect sleep by causing insomnia, and the timing of the second dose is critical to minimize this risk.

Mechanism and Sleep Impact

Bupropion is classified as an "activating" antidepressant that works through dopamine and norepinephrine reuptake inhibition, which inherently promotes wakefulness rather than sedation 1. This activating property distinguishes it from sedating antidepressants like mirtazapine or trazodone 1.

The most common side effects of bupropion include trouble sleeping, feeling anxious, and nervousness 2. In clinical studies, insomnia is consistently reported as one of the primary adverse effects 3, 4.

Critical Dosing Timing to Minimize Insomnia

To minimize the risk of insomnia, guidelines explicitly recommend giving the second dose of bupropion before 3 p.m. 1. This timing recommendation is based on the drug's activating properties and its potential to interfere with sleep initiation if taken too late in the day.

The FDA-approved labeling reinforces this concern, stating: "If you have trouble sleeping, do not take bupropion hydrochloride extended-release tablets (XL) too close to bedtime" 2.

Sleep Architecture Effects

Beyond subjective insomnia complaints, bupropion has measurable effects on sleep architecture:

  • Bupropion increases REM sleep latency (the time it takes to enter REM sleep), particularly in treatment responders 5
  • This REM suppression effect is characteristic of many antidepressants but is mediated through different mechanisms with bupropion—likely via dopamine D2 receptors or noradrenergic pathways rather than serotonergic effects 5
  • The relationship between REM latency changes and clinical response suggests these sleep effects may be linked to the drug's therapeutic mechanism 5

Clinical Management Recommendations

For your patient taking 75mg BID:

  • Ensure the second dose is administered no later than 3 p.m. to reduce insomnia risk 1
  • Monitor for complaints of difficulty falling asleep, staying asleep, or feeling overstimulated in the evening 2, 3
  • Consider that nervousness and agitation may accompany the sleep disturbance 3, 6

If insomnia develops despite proper timing:

  • The dose may need adjustment or the medication may need to be changed to a less activating antidepressant 1
  • Unlike SSRIs, bupropion does not have serotonergic effects that contribute to sleep disturbance, so the insomnia is primarily related to its dopaminergic/noradrenergic activation 3, 6

Important Caveats

  • The 75mg BID dosing (total 150mg daily) is within the therapeutic range but lower than maximum doses, which may result in less pronounced sleep effects than higher doses 1
  • Individual sensitivity varies considerably—some patients tolerate bupropion well without sleep disturbance, while others experience significant insomnia even at lower doses 4
  • Bupropion has significantly less sexual dysfunction and somnolence compared to SSRIs, making it advantageous for patients who experienced these side effects with other antidepressants 4

Related Questions

What is the most similar option to Wellbutrin (bupropion)?
What is the proper dosage and usage of Wellbutrin (bupropion) for treating depression and seasonal affective disorder?
What are the approved and off‑label uses, dosing regimens, contraindications, and alternative therapies for bupropion (including Zyban)?
Why am I unable to use bupropion (Wellbutrin) and low‑dose doxepin for insomnia together with a transdermal estradiol patch and oral progesterone, given that I cannot take selective serotonin reuptake inhibitors (SSRIs) or serotonin‑norepinephrine reuptake inhibitors (SNRIs)?
What sleep aid can be safely taken with bupropion (Wellbutrin)?
Will the CYP2D6 liver enzyme competition between Abilify (Aripiprazole) and Strattera (Atomoxetine) contribute to insomnia, and will this interaction recur with Viloxazine?
What is the diagnosis and treatment plan for a patient with a positive Antinuclear Antibody (ANA) test showing a speckled pattern, elevated Complement 3 (C3) levels, and high Anti-Thyroid Peroxidase (Anti-TPO) antibody levels?
How does Viloxazine (Viloxazine) compare to Strattera (Atomoxetine) in terms of metabolic pathways and risk of insomnia?
What is the recommended follow-up for a cavernoma that is too small to characterize?
Can a patient start with once daily 100mg of bupropion (Wellbutrin) in the morning?
What is the most appropriate treatment approach for a patient with right shoulder instability and multiple associated conditions, who has undergone previous surgeries including arthroscopic glenoid reconstruction and axillary nerve neurolysis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.